Prihlásiť sa Zaregistrujte sa zadarmo

Zamestnanci spoločnosti AC Immune SA

Aká je hodnota metriky Zamestnanci spoločnosti AC Immune SA?

Hodnota metriky Zamestnanci spoločnosti AC Immune SA je 169

Aká je definícia metriky Zamestnanci?

Zamestanci (Employees) je počet zamestnancov spoločnosti, ktorí pracujú za plat vo forme zodpovedajúcej typu práce a sektoru, v ktorom pracujú.

Employment is a relationship between two parties, usually based on a contract where work is paid for, where one party, which may be a corporation, for profit, not-for-profit organization, co-operative or other entity is the employer and the other is the employee.

Employees in some fields or sectors may receive gratuities, bonus payment or stock options. In some types of employment, employees may receive benefits in addition to payment. Benefits can include health insurance, housing, disability insurance or use of a gym. Employment is typically governed by employment laws or regulations or legal contracts.

Zamestnanci spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou AC Immune SA

Čomu sa venuje spoločnosť AC Immune SA?

ac immune is a clinical-stage swiss-based biopharmaceutical company, listed on nasdaq, which aims to become a global leader in precision medicine for neurodegenerative diseases. the company designs, discovers and develops therapeutic as well as diagnostic products intended to prevent and modify diseases caused by misfolding proteins. ac immune’s two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as alzheimer’s disease (ad). the company’s pipeline features nine therapeutic and three diagnostic product candidates – with five product candidates currently in clinical trials. the most advanced of these is crenezumab, a humanized anti-amyloid-β monoclonal igg4 antibody that targets monomeric and aggregated forms of amyloid-β, with highest affinity for neurotoxic oligomers. crenezumab is currently in two phase 3 clinical studies for ad, under a global program conducted by the collabor

Firmy s metrikou zamestnanci podobnou spoločnosti AC Immune SA